Viewing Study NCT02318693


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-02 @ 4:03 AM
Study NCT ID: NCT02318693
Status: COMPLETED
Last Update Posted: 2018-08-21
First Post: 2014-12-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
Sponsor: Merck Sharp & Dohme LLC
Organization: